Reply to Comment on: Descemet Stripping Endothelial Keratoplasty in Pediatric Patients with Congenital Hereditary Endothelial Dystrophy

Abstract

We appreciate comments on our paper. 1 Yang F. Hong J. Xiao G. et al. Descemet stripping endothelial keratoplasty in pediatric patients with congenital hereditary endothelial dystrophy. Am J Ophthalmol. 2020; 209: 132-140 Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar Although Descemet's membrane endothelial keratoplasty (DMEK) shows an advantage in adults compared with Descemet stripping endothelial keratoplasty (DSEK), 2 Woo J.H. Ang M. Myint Htoon H. Tan D. Descemet membrane endothelial keratoplasty versus Descemet stripping automated endothelial keratoplasty and penetrating keratoplasty. Am J Ophthalmol. 2019; 207: 288-303 Abstract Full Text Full Text PDF PubMed Scopus (49) Google Scholar we do not recommend DMEK in pediatric patients because of the great anatomic and physiologic differences between adults and children. Comment on Descemet Stripping Endothelial Keratoplasty in Pediatric Patients with Congenital Hereditary Endothelial DystrophyAmerican Journal of OphthalmologyVol. 215PreviewWe congratulate Yang and associates1 for their success in reporting specificities and long-term results of Descemet stripping endothelial keratoplasty (DSEK) in children. We share the opinions about the likely superiority of endothelial keratoplasty (EK) over penetrating keratoplasty (PK) in this age group, regarding amblyopia, rejection, or traumatic dehiscence.2,3 However, we would like to point out the advantages of Descemet membrane endothelial keratoplasty (DMEK) over DSEK in this population. Full-Text PDF